Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Titanium is a transition metal (atomic number 22, symbol Ti) known for its outstanding strength-to-density ratio, corrosion resistance, and high biocompatibility[1][2][4][6]. It is widely employed for aerospace, industrial, and medical uses, including implants and prostheses, due to its combination of high strength, low density, and resistance to bodily fluids[4][2][6]. Titanium is not a biological macromolecule or therapeutic target but is valued for its physical and chemical properties in engineering and biomedicine. Titanium is often confused as a "target" due to its prevalence in medical devices, but it is not a receptor, enzyme, or molecular biological entity in the drug discovery sense. It should not be considered a valid entry in drug target databases.
None applicable (titanium is not a biological or pharmacological target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Titanium (Ti).